Impact of FIGO 2023 Staging on MRI Evaluation of Endometrial Cancer: Highlighted Version
Journal of Gastrointestinal and Abdominal Radiology · 01.09.2026 · 09 (03) · 199-209
DOI: 10.1055/s-0045-1815706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Abdominal Radiology, erschienen am 01.09.2026. Verfasst von Seema Sud und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The 2023 revision of the International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial carcinoma (EC) has introduced significant updates, including refined anatomic definitions and the incorporation of molecular subtypes such as POLE mutations, mismatch repair deficiency, and p53 abnormalities. Magnetic resonance imaging (MRI) remains the preferred modality for preoperative staging of EC due to its superior soft tissue contrast and functional imaging capabilities. This review discusses the technical considerations for MRI acquisition, with particular emphasis on the impact of the revised staging system on imaging interpretation. It highlights the role of MRI in evaluating eligibility for fertility-sparing treatments and in posttreatment surveillance. Radiologists must be familiar with these changes to ensure accurate staging and optimal patient management. Lastly, it elucidates the utility of imaging biomarkers such as apparent diffusion coefficient values, tumor size, and patterns of spread as potential surrogates for histologic and molecular classification. Integrating molecular profiling with MRI interpretation represents a critical advancement toward risk-adapted therapeutic strategies in endometrial cancer.
Zitieren
APA
Sud, S., Sarvankar, K. M., & Ghuman, S. S. (2026). Impact of FIGO 2023 Staging on MRI Evaluation of Endometrial Cancer: Highlighted Version. Journal of Gastrointestinal and Abdominal Radiology, 09(03), 199-209. https://doi.org/10.1055/s-0045-1815706
Vancouver
Sud S, Sarvankar KM, Ghuman SS. Impact of FIGO 2023 Staging on MRI Evaluation of Endometrial Cancer: Highlighted Version. Journal of Gastrointestinal and Abdominal Radiology. 2026;09(03):199-209. doi:10.1055/s-0045-1815706
BibTeX
@article{Sud2026,
author = {Sud, Seema and Sarvankar, Ketki Mahendra and Ghuman, Samarjit Singh},
title = {Impact of FIGO 2023 Staging on MRI Evaluation of Endometrial Cancer: Highlighted Version},
journal = {Journal of Gastrointestinal and Abdominal Radiology},
year = {2026},
volume = {09},
number = {03},
pages = {199--209},
doi = {10.1055/s-0045-1815706}
}
EUVIMED